Related references
Note: Only part of the references are listed.Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2
Hanjun Zhao et al.
NATURE COMMUNICATIONS (2021)
The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases
Juan Antonio Vizcaino et al.
MOLECULAR & CELLULAR PROTEOMICS (2020)
Electrical recognition of the twenty proteinogenic amino acids using an aerolysin nanopore
Hadjer Ouldali et al.
NATURE BIOTECHNOLOGY (2020)
Mass spectrometry based identification of MHC-bound peptides for immunopeptidomics
Anthony W. Purcell et al.
NATURE PROTOCOLS (2019)
Alternative tumour-specific antigens
Christof C. Smith et al.
NATURE REVIEWS CANCER (2019)
High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome
Chloe Chong et al.
MOLECULAR & CELLULAR PROTEOMICS (2018)
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Diego Chowell et al.
SCIENCE (2018)
Extracellular vesicles in cancer - implications for future improvements in cancer care
Rong Xu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Exosomes in cancer: Use them or target them?
Nuno Bastos et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
Identification of single amino acid differences in uniformly charged homopolymeric peptides with aerolysin nanopore
Fabien Piguet et al.
NATURE COMMUNICATIONS (2018)
Noncoding regions are the main source of targetable tumor-specific antigens
Celine M. Laumont et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens
Sandra Wagner et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
A Molecular Basis for the Presentation of Phosphorylated Peptides by HLA-B Antigens
Adab Alpizar et al.
MOLECULAR & CELLULAR PROTEOMICS (2017)
The major histocompatibility complex class I immunopeptidome of extracellular vesicles
Silvia A. Synowsky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data
Vanessa Jurtz et al.
JOURNAL OF IMMUNOLOGY (2017)
Data-Independent Acquisition of HLA Class I Peptidomes on the Q Exactive Mass Spectrometer Platform
Danilo Ritz et al.
PROTEOMICS (2017)
Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation
Marek Wieczorek et al.
FRONTIERS IN IMMUNOLOGY (2017)
Cancer Neoantigens and Applications for Immunotherapy
Alexis Desrichard et al.
CLINICAL CANCER RESEARCH (2016)
Extracellular vesicles as carriers of microRNA, proteins and lipids in tumor microenvironment
Patrice Penfornis et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
Benjamin Besse et al.
ONCOIMMUNOLOGY (2016)
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
Mercedes Tkach et al.
CELL (2016)
The biology and function of exosomes in cancer
Raghu Kalluri
JOURNAL OF CLINICAL INVESTIGATION (2016)
Exosomal proteins as prognostic biomarkers in non-small cell lung cancer
B. Sandfeld-Paulsen et al.
MOLECULAR ONCOLOGY (2016)
A large fraction of HLA class I ligands are proteasome-generated spliced peptides
Juliane Liepe et al.
SCIENCE (2016)
Massive release of extracellular vesicles from cancer cells after photodynamic treatment or chemotherapy
Kelly Aubertin et al.
SCIENTIFIC REPORTS (2016)
A Theoretical Justification for Single Molecule Peptide Sequencing
Jagannath Swaminathan et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and Opportunities
Bo Hong et al.
CURRENT DRUG TARGETS (2014)
Regulation of exosome release from mammary epithelial and breast cancer cells - A new regulatory pathway
Andrew Riches et al.
EUROPEAN JOURNAL OF CANCER (2014)
miR-200-containing extracellular vesicles promote breast cancer cell metastasis
Minh T. N. Le et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Extracellular vesicles in physiological and pathological conditions
Yuana Yuana et al.
BLOOD REVIEWS (2013)
Exosomes in tumor microenvironment influence cancer progression and metastasis
Christoph Kahlert et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Extracellular vesicles: biology and emerging therapeutic opportunities
Samir EL Andaloussi et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
As we wait: coping with an imperfect nomenclature for extracellular vesicles
Stephen J. Gould et al.
JOURNAL OF EXTRACELLULAR VESICLES (2013)
Microparticles and their emerging role in cancer multidrug resistance
J. Gong et al.
CANCER TREATMENT REVIEWS (2012)
Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages
Cecilia Lasser et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8+ T Lymphocytes
Eva U. Wieckowski et al.
JOURNAL OF IMMUNOLOGY (2009)
Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15Rα
Sophie Viaud et al.
PLOS ONE (2009)
Membrane vesicles as conveyors of immune responses
Clotilde Thery et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Human tumor-derived exosomes selectively impair lymphocyte responses to interieukin-2
Aled Clayton et al.
CANCER RESEARCH (2007)
Direct exosome stimulation of peripheral human T cells detected by ELISPOT
Charlotte Admyre et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes:: results of thefirst phase I clinical trial
B Escudier et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
MA Morse et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
J Wolfers et al.
NATURE MEDICINE (2001)
Share Paper
